| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/09/2023 | 42.86% | Needham | $10 → $8 | Maintains | Buy |
| 09/22/2023 | 42.86% | Cantor Fitzgerald | → $8 | Reiterates | Overweight → Overweight |
| 09/22/2023 | 42.86% | Goldman Sachs | $7 → $8 | Maintains | Buy |
| 09/22/2023 | 78.57% | Needham | → $10 | Reiterates | Buy → Buy |
| 08/09/2023 | 78.57% | Needham | → $10 | Reiterates | Buy → Buy |
| 07/11/2023 | 25% | Berenberg | → $7 | Initiates Coverage On | → Buy |
| 05/10/2023 | 42.86% | Keefe, Bruyette & Woods | $9 → $8 | Maintains | Outperform |
| 05/10/2023 | 60.71% | Citigroup | $11 → $9 | Maintains | Buy |
| 05/10/2023 | 78.57% | Needham | → $10 | Reiterates | → Buy |
| 03/22/2023 | 78.57% | Needham | → $10 | Reiterates | → Buy |
| 03/02/2023 | 96.43% | Citigroup | $10 → $11 | Maintains | Buy |
| 03/01/2023 | 78.57% | Needham | → $10 | Reiterates | → Buy |
| 02/27/2023 | 25% | Jefferies | → $7 | Initiates Coverage On | → Buy |
| 01/11/2023 | 25% | Wolfe Research | → $7 | Initiates Coverage On | → Outperform |
| 01/09/2023 | 16.07% | Goldman Sachs | $9 → $6.5 | Maintains | Buy |
| 11/10/2022 | 78.57% | Citigroup | $9 → $10 | Maintains | Buy |
| 11/10/2022 | 78.57% | Needham | $9 → $10 | Maintains | Buy |
| 10/05/2022 | 69.64% | Goldman Sachs | $8.5 → $9.5 | Maintains | Buy |
| 08/12/2022 | 60.71% | Needham | $7 → $9 | Maintains | Buy |
| 07/14/2022 | 16.07% | Goldman Sachs | $5.5 → $6.5 | Upgrades | Neutral → Buy |
| 05/13/2022 | 33.93% | Citigroup | $6.5 → $7.5 | Maintains | Buy |
| 03/04/2022 | 25% | Needham | $13 → $7 | Maintains | Buy |
| 01/26/2022 | 96.43% | Citigroup | $12.5 → $11 | Maintains | Buy |
| 12/10/2021 | 51.79% | Goldman Sachs | → $8.5 | Initiates Coverage On | → Neutral |
| 09/24/2021 | 123.21% | Citigroup | → $12.5 | Initiates Coverage On | → Buy |
| 08/03/2021 | — | William Blair | Initiates Coverage On | → Outperform | |
| 07/28/2021 | 132.14% | Cantor Fitzgerald | → $13 | Initiates Coverage On | → Overweight |
| 07/23/2021 | 105.36% | Goldman Sachs | → $11.5 | Initiates Coverage On | → Neutral |
| 07/22/2021 | 132.14% | Needham | → $13 | Initiates Coverage On | → Buy |
| 07/21/2021 | 150% | Keefe, Bruyette & Woods | → $14 | Initiates Coverage On | → Outperform |
What is the target price for Payoneer Global (PAYO)?
The latest price target for Payoneer Global (NASDAQ: PAYO) was reported by Needham on November 9, 2023. The analyst firm set a price target for $8.00 expecting PAYO to rise to within 12 months (a possible 42.86% upside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Payoneer Global (PAYO)?
The latest analyst rating for Payoneer Global (NASDAQ: PAYO) was provided by Needham, and Payoneer Global maintained their buy rating.
When is the next analyst rating going to be posted or updated for Payoneer Global (PAYO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Payoneer Global, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Payoneer Global was filed on November 9, 2023 so you should expect the next rating to be made available sometime around November 9, 2024.
Is the Analyst Rating Payoneer Global (PAYO) correct?
While ratings are subjective and will change, the latest Payoneer Global (PAYO) rating was a maintained with a price target of $10.00 to $8.00. The current price Payoneer Global (PAYO) is trading at is $5.60, which is out of the analyst's predicted range.